Trial Profile
Clinical Trials Insight: 700013891
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2006
Price :
$35
*
At a glance
- Drugs Bederocin (Primary)
- Indications Impetigo; Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- Sponsors Cardiovascular Systems
- 20 Jul 2006 New trial record.